A detailed history of Quadrant Capital Group LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Quadrant Capital Group LLC holds 2,424 shares of TEVA stock, worth $43,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,424
Previous 2,041 18.77%
Holding current value
$43,316
Previous $28,000 39.29%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$12.78 - $17.4 $4,894 - $6,664
383 Added 18.77%
2,424 $39,000
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $5,847 - $7,907
548 Added 36.7%
2,041 $28,000
Q4 2023

Feb 08, 2024

SELL
$8.12 - $10.63 $7,031 - $9,205
-866 Reduced 36.71%
1,493 $15,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $14,952 - $21,389
1,999 Added 555.28%
2,359 $24,000
Q2 2023

Aug 09, 2023

SELL
$7.2 - $9.47 $9,583 - $12,604
-1,331 Reduced 78.71%
360 $2,000
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $3,452 - $4,695
413 Added 32.32%
1,691 $14,000
Q4 2022

Feb 10, 2023

BUY
$7.95 - $9.48 $2,893 - $3,450
364 Added 39.82%
1,278 $11,000
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $1,035 - $1,804
-151 Reduced 14.18%
914 $7,000
Q2 2022

Aug 09, 2022

BUY
$7.38 - $10.4 $5,992 - $8,444
812 Added 320.95%
1,065 $8,000
Q1 2022

May 06, 2022

SELL
$7.33 - $9.39 $6,149 - $7,878
-839 Reduced 76.83%
253 $2,000
Q4 2021

Feb 01, 2022

BUY
$7.9 - $10.19 $5,656 - $7,296
716 Added 190.43%
1,092 $9,000
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $695 - $844
83 Added 28.33%
376 $4,000
Q2 2021

Aug 09, 2021

SELL
$9.9 - $11.56 $227 - $265
-23 Reduced 7.28%
293 $3,000
Q1 2021

May 12, 2021

BUY
$10.34 - $12.81 $496 - $614
48 Added 17.91%
316 $4,000
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $1,541 - $1,976
179 Added 201.12%
268 $3,000
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $299 - $444
-35 Reduced 28.23%
89 $1,000
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $123,050 - $198,820
-15,154 Reduced 99.19%
124 $2,000
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $9,673 - $19,448
1,446 Added 10.45%
15,278 $137,000
Q4 2019

Feb 03, 2020

BUY
$6.53 - $10.72 $90,094 - $147,903
13,797 Added 39420.0%
13,832 $133,000
Q3 2019

Oct 24, 2019

SELL
$6.16 - $9.6 $81,077 - $126,355
-13,162 Reduced 99.73%
35 $0
Q2 2019

Jul 24, 2019

BUY
$8.12 - $15.72 $51,423 - $99,554
6,333 Added 92.26%
13,197 $120,000
Q1 2019

Apr 29, 2019

BUY
$15.58 - $20.01 $20,612 - $26,473
1,323 Added 23.88%
6,864 $104,000
Q4 2018

Jan 17, 2019

BUY
$14.59 - $23.84 $65,304 - $106,707
4,476 Added 420.28%
5,541 $80,000
Q3 2018

Oct 29, 2018

BUY
$21.06 - $25.65 $7,560 - $9,208
359 Added 50.85%
1,065 $19,000
Q2 2018

Aug 09, 2018

SELL
$16.77 - $24.71 $3,404 - $5,016
-203 Reduced 22.33%
706 $15,000
Q1 2018

May 10, 2018

BUY
$16.68 - $22.07 $10,625 - $14,058
637 Added 234.19%
909 $11,000
Q4 2017

Jan 31, 2018

SELL
$11.23 - $19.1 $1,370 - $2,330
-122 Reduced 30.96%
272 $4,000
Q3 2017

Oct 13, 2017

SELL
$15.41 - $32.17 $2,481 - $5,179
-161 Reduced 29.01%
394 $4,000
Q2 2017

Aug 15, 2017

BUY
N/A
555
555 $12,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.